col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Chemical Society: ACS Pharmacology & Translational Science
  original article Date Title Authors   All Authors
1 [GO] 2021―Jun―09 Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir Zilei Xia, Michael Sacco, Yanmei Hu, Chunlong Ma, Xiangzhi Meng, Fushun Zhang, et al. (+4)
2 [GO] 2021―Apr―29 Correction to “Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir” Ting Chen, Cheng-Yin Fei, Yi-Ping Chen, Karen Sargsyan, Jian-Jong Liang, Chun-Che Liao, et al. (+4)
3 [GO] 2021―Apr―16 Identification of Novel MicroRNAs Targeting SARS-CoV-2 through the Regulation of TMPRSS2/PI3K/AKT/PTEN Alignment in Lung Cancer: An in Silico Analysis Debasmita Mukhopadhyay, Nour AlSawaftah, Ghaleb A Husseini
4 [GO] 2021―Apr―02 Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19 Xin Hu, Jonathan H. Shrimp, Hui Guo, Miao Xu, Catherine Z. Chen, Wei Zhu, et al. (+6)
5 [GO] 2021―Mar―26 Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir Ting Chen, Cheng-Yin Fei, Yi-Ping Chen, Karen Sargsyan, Chun-Ping Chang, Hanna S. Yuan, Carmay Lim
6 [GO] 2021―Mar―22 Repurposing Quinoline and Artemisinin Antimalarials as Therapeutics for SARS-CoV-2: Rationale and Implications Tessa M. Firestone, Opeoluwa O. Oyewole, St Patrick Reid, Caroline L. Ng
7 [GO] 2021―Mar―19 COVID-19: Is There a Link between Alcohol Abuse and SARS-CoV-2-Induced Severe Neurological Manifestations? Jibran Sualeh Muhammad, Ruqaiyyah Siddiqui, Naveed Ahmed Khan
8 [GO] 2021―Mar―17 A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics Jonas Gossen, Simone Albani, Anton Hanke, Benjamin P. Joseph, Cathrine Bergh, Maria Kuzikov, et al. (+14)
9 [GO] 2021―Mar―11 Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, et al. (+27)
10 [GO] 2021―Mar―04 COVID-19: Does SARS-CoV-2 Modulate Acanthamoeba Epigenetics to Enhance Survival and Transmission in the Environment? Jibran Sualeh Muhammad, Ruqaiyyah Siddiqui, Naveed Ahmed Khan
11 [GO] 2021―Mar―01 Toward the Next-Generation COVID-19 Vaccines That Circumvent Antigenic Drift while Defusing Viral Infection Ariel Fernández
12 [GO] 2021―Feb―05 SARS-CoV-2 Glycosylation Suggests That Vaccines Should Have Adopted the S1 Subunit as Antigen Ariel Fernández
13 [GO] 2021―Jan―29 Docking Prediction of Levodopa in the Receptor Binding Domain of Spike Protein of SARS-CoV-2 Abdul Mannan Baig, Areeba Khaleeq, Hira Syeda, Noor Bibi
14 [GO] 2021―Jan―21 Glycosylation of SARS-CoV-2 Steers Evolutionary Outcomes in the Postvaccination Phase Ariel Fernández
15 [GO] 2021―Jan―15 Diagnostic, Prognostic, and Therapeutic Use of Radiopharmaceuticals in the Context of SARS-CoV-2 Roger M. Pallares, Rebecca J. Abergel
16 [GO] 2021―Jan―10 SARS-CoV-2, Hypoxia, and Calcium Signaling: The Consequences and Therapeutic Options Chhanda Charan Danta
17 [GO] 2020―Dec―31 COVID-19 Evolution in the Post-Vaccination Phase: Endemic or Extinct? Ariel Fernández
18 [GO] 2020―Dec―30 Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model Prashant Dogra, Javier Ruiz-Ramírez, Kavya Sinha, Joseph D. Butner, Maria J. Peláez, Manmeet Rawat, et al. (+6)
19 [GO] 2020―Dec―29 Antibacterial and Antiviral Functional Materials: Chemistry and Biological Activity toward Tackling COVID-19-like Pandemics Bhuvaneshwari Balasubramaniam, Sudhir Ranjan, Mohit Saraf, Prasenjit Kar, Surya Pratap Singh, Vijay Kumar Thakur, et al. (+2)
20 [GO] 2020―Dec―12 Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial Leticia R. Cruz, Idania Baladrón, Aliusha Rittoles, Pablo A. Díaz, Carmen Valenzuela, Raúl Santana, et al. (+19)
21 [GO] 2020―Dec―09 Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An In Silico Analysis Debasmita Mukhopadhyay, Nour AlSawaftah, Ghaleb A. Husseini
22 [GO] 2020―Dec―01 Clinically Approved Antiviral Drug in an Orally Administrable Nanoparticle for COVID-19 Bapurao Surnar, Mohammad Z. Kamran, Anuj S. Shah, Shanta Dhar
23 [GO] 2020―Nov―17 Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay Quinlin M. Hanson, Kelli M. Wilson, Min Shen, Zina Itkin, Richard T. Eastman, Paul Shinn, Matthew D. Hall
24 [GO] 2020―Nov―11 Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2 Ke Liu, Rongfeng Zou, Wenqiang Cui, Meiqing Li, Xueying Wang, Junlin Dong, et al. (+8)
25 [GO] 2020―Nov―07 Probing the Dynamic Structure-Function and Structure-Free Energy Relationships of the Coronavirus Main Protease with Biodynamics Theory Hongbin Wan, Vibhas Aravamuthan, Robert A. Pearlstein
26 [GO] 2020―Nov―03 Docking Prediction of Amantadine in the Receptor Binding Domain of Spike Protein of SARS-CoV-2 Abdul Mannan Baig, Areeba Khaleeq, Hira Syeda
27 [GO] 2020―Oct―19 Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles Catherine Z. Chen, Miao Xu, Manisha Pradhan, Kirill Gorshkov, Jennifer D. Petersen, Marco R. Straus, et al. (+9)
28 [GO] 2020―Oct―15 Defusing SARS-CoV-2: Emergency Brakes in a Vaccine Failure Scenario Ariel Fernández
29 [GO] 2020―Oct―14 Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19 Giovanni Bocci, Steven B. Bradfute, Chunyan Ye, Matthew J. Garcia, Jyothi Parvathareddy, Walter Reichard, et al. (+7)
30 [GO] 2020―Oct―09 Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors Chunlong Ma, Yanmei Hu, Julia Alma Townsend, Panagiotis I. Lagarias, Michael Thomas Marty, Antonios Kolocouris, Jun Wang
31 [GO] 2020―Oct―09 Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid Kirill Gorshkov, Catherine Z. Chen, Miao Xu, Juan Carlos de la Torre, Luis Martinez-Sobrido, Thomas Moran, Wei Zheng
32 [GO] 2020―Sep―30 Helminths and COVID-19 Co-Infections: A Neglected Critical Challenge Amir Abdoli
33 [GO] 2020―Sep―28 Ivermectin, Famotidine, and Doxycycline: A Suggested Combinatorial Therapeutic for the Treatment of COVID-19 Parth Sarthi Sen Gupta, Malay Kumar Rana
34 [GO] 2020―Sep―28 Heme/Hemeoxygenase-1 System Is a Potential Therapeutic Intervention for COVID-19 Patients with Severe Complications Biplab K Maiti
35 [GO] 2020―Sep―18 SARS-CoV-2 vaccine development: An overview and perspectives Yi Liu, Kai Wang, Tarik F. Massoud, Ramasamy Paulmurugan
36 [GO] 2020―Sep―15 Achilles’ Heel of SARS-CoV-2 Structure Ariel Fernández
37 [GO] 2020―Sep―08 Can SARS-CoV-2 Accumulate Mutations in the S-Protein to Increase Pathogenicity? Aditya K. Padhi, Timir Tripathi
38 [GO] 2020―Sep―07 An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19 Jonathan H. Shrimp, Stephen C. Kales, Philip E. Sanderson, Anton Simeonov, Min Shen, Matthew D. Hall
39 [GO] 2020―Sep―04 Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening Wei Zhu, Miao Xu, Catherine Z. Chen, Hui Guo, Min Shen, Xin Hu, et al. (+4)
40 [GO] 2020―Sep―01 Therapeutically Targeted Destabilization of the Quaternary Structure of the Spike Protein in the Dominant G614 Strain of SARS-CoV-2 Ariel Fernández
41 [GO] 2020―Aug―27 Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19 Dhanusha Nalawansha, Kusal Samarasinghe
42 [GO] 2020―Aug―18 Dipeptidyl Peptidase-4: A Potential Therapeutic Target in Diabetic Kidney Disease with SARS-CoV-2 Infection Chhanda Charan Danta
43 [GO] 2020―Aug―04 Can Papain-like Protease Inhibitors Halt SARS-CoV-2 Replication? Biplab K Maiti
44 [GO] 2020―Jul―30 Potential therapeutic agents and associated bioassay data for COVID-19 and related human coronavirus infections Qiongqiong Zhou, Junko Kato-Weinstein, Yingzhu Li, Yi Deng, Roger Granet, Linda Garner, et al. (+4)
45 [GO] 2020―Jul―24 Potential Role of Peptide-Based Antiviral Therapy Against SARS-CoV-2 Infection Biplab K. Maiti
46 [GO] 2020―Jul―23 SARS-CoV-2 receptor ACE2 is enriched in a subpopulation of mouse tongue epithelial cells in non-gustatory papillae, but not in taste buds or embryonic oral epithelium Zhonghou Wang, Jingqi Zhou, Brett Marshall, Romdhane Rekaya, Kaixiong Ye, Hong-Xiang Liu
47 [GO] 2020―Jun―16 The Potential of Antimicrobial Peptides as an Antiviral Therapy against COVID-19 Sherif Elnagdy, Maha AlKhazindar


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.020 sec